Ultracet Articles
Labopharm in trouble over 11% deeper loss
16 March 2009
Labopharm's once-daily Ryzolt cleared by FDA
12 January 2009
UK warning on Internet Rx drugs
15 December 2008
Largest fake drug haul in Europe from India
13 October 2008
Labopharma regains UK tramadol rights
14 July 2008
Labopharm appeals rejection of tramadol
14 April 2008
Labopharm
18 February 2008
Labopharm licenses tramadol to iNova for Australia
4 February 2008
Biovail and Janssen sign tramadol supply and distribution accord
14 January 2008
Labopharm to appeal US rejection of NDA
3 December 2007
Biovail launches Ralivia to Canadian physicians
12 November 2007
Labopharm asks to discuss tramadol NDA with FDA
27 September 2007
Par and Ortho-McNeil resolve Ultracet patent dispute
30 July 2007
Labopharm hit by second FDA letter
11 June 2007
Tramadol gets second FDA approvable letter
11 June 2007
Caraco wins generic Ultracet appeal
29 January 2007
Labopharm completes response to FDA
22 January 2007
Labopharm responds to FDA approvable letter on tramadol
22 December 2006
FDA raises questions on Labopharm's tramadol
9 October 2006
Labopharm licenses tramadol to GSK in Mexico
5 June 2006
J&J's 1st-qtr 2006 earnings up 16.4%, but sales weak
24 April 2006
Biovail's 2005 revenue reaches $936M
3 April 2006
Labopharm reports C$33.3 M losses in 2005
27 February 2006
J&J's 4th-qtr 2005 sales drop 1.1% on low Rx
30 January 2006
US orphan status for TheraQuest's TQ-1017
22 August 2005
Tentative US approval for Teva's tramadol
25 July 2005
Viatris a takeover target for Indian firms?
18 July 2005
US FDA approves Biovail's Tramadol ODR
16 May 2005
US FDA asks for more trials of Biovail's Tramadol
18 April 2005
FDA seeks more trials for Biovail's pain drug
11 April 2005
Panel endorses use of Gruenenthal's Zydol
21 February 2005
Biovail get approvable letter for tramadol
24 January 2005
Labopharm's tramadol cleared in France
24 January 2005
Grunenthal opens UK and Ireland office
17 January 2005
Bioavail's Raliva ER gets approvable letter
8 November 2004
Labopharm reduces losses in 3rd qtr
1 November 2004
Par Pharma buys Kali Labs in $135M deal
21 June 2004
Pharmaceutical Resources to buy Kali
19 April 2004
Biovail files NDA for Ralivia FlashDose
22 March 2004
Biovail revises 2004 guidance
15 March 2004
Second FDA drug imports "blitz" finds 80% come from Canada
9 February 2004
Labopharm shares up
29 September 2003
Promising Ph III data for DOV's bicifadine
22 September 2003
Labopharm finalizes Italian distribution for tramadol
4 August 2003
Labopharm to turn profitable in 2004
30 June 2003
Caraco expects $35M revenues in 2003
24 February 2003
LaboPharm's losses up in 3rd quarter
27 January 2003
Labopharm set to file tramadol in 1Q?
27 January 2003
Labopharm starts pivotal tramadol OD trials
20 January 2003
Teva's net income leaps 43% in 2nd qtr
12 August 2002
Ethypharm, VIATRIS' tramadol Flashtab
1 July 2002
Alpharma gets generic tramadol go-ahead in USA
1 July 2002
Labopharm losses deepen
29 April 2002
Caraco gets US OK for metformin/tramadol
4 February 2002
IVAX' paclitaxel gets ok to stay on US market
4 February 2002
J&J posts healthy increase in sales and earnings for 2001
28 January 2002
Labopharm sets up European subsidiary in Ireland.
21 January 2002
Grupo Vita begins Ph I VANH36 study
27 September 2001
Extended-release tramadol shows promise
7 September 2001
Zyban warnings are strengthened in UK
1 June 2001
Johnson & Johnson net earnings rise 15.5%
19 April 2000
Healthy full-year results for many US pharmaceutical companies
27 January 2000
Roberts' propiram betters tramadol in Phase III
18 March 1999
Gruenenthal To Expand In France
27 October 1998
USA's Most-Dispensed Rx Drugs In April 1998
20 May 1998
Asta Comes Through Tough Year, Looks To Expansion
4 March 1998
Strong Growth For US Drug Firms In 1997
28 January 1998
Zeneca Allays Fears Of Near-Term Product Gap
4 December 1997
First Approval Of AHP's Duract
17 July 1997
UK Industry Code Of Practice Review
2 July 1997
Strong $ Impact On 1st Qtr At Johnson & Johnson
22 April 1997
Significant Increases For US Drug Firms In 1996
3 February 1997
Major US Drug Cos Post Strong Results In 3rd Qtr
28 October 1996
US Drug Majors See 2nd-Half Double-Digit Growth
29 July 1996
US Firms' Strong 1st Qtr Lifts Share Prices
29 April 1996
Tramadol Labeling Changes
15 April 1996
Transition For AHP in 1995; Year-End Results
5 February 1996
UK Code Of Practice Amendments, New Report
25 September 1995
US FDA Approving Fewer NMEs, But Faster, In 1995
11 September 1995
Strong International Sales For US Cos In 2nd Qtr
31 July 1995
UK Code Authority May Become Self-Supporting
20 March 1995
NSAID Debate Continues Apace In USA
13 March 1995
SEARLE LAUNCH IN UK
13 June 1994
Showing 1-94 of 94 articles
- 1
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- US Supreme Court says patent settlement can "sometimes" be illegal
